| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Young-Jin Kim M.B.A. CEO | KRX SM Exchange | KR7002390003 ISIN |
| KR Country | 938 Employees | - Last Dividend | 2 May 2003 Last Split | - IPO Date |
HANDOK Inc., originally established as Handok Pharmaceuticals Co., Ltd, has evolved into a prominent pharmaceutical company since its inception in 1954. Based in Seoul, South Korea, the company underwent a significant rebranding in July 2013, reflecting its broadened focus and commitment towards healthcare innovation. HANDOK Inc. is dedicated to improving quality of life through a diverse range of healthcare solutions, encompassing both prescription (ETC) and over-the-counter (OTC) drugs, alongside advanced medical devices and research products. The company zeroes in on a myriad of therapeutic areas, including but not limited to oncology, diabetes, metabolic disorders, central nervous system (CNS) diseases, orphan diseases, and eye disorders. Beyond pharmaceuticals, HANDOK Inc. extends its portfolio to include healthcare products under the NatureSet brand, offering food supplements, a selection of food and beverages, and medical nutrition products, thereby catering to a comprehensive spectrum of healthcare needs.